Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
Yanjing Li(Duke University), Jiaoti Huang(Space Science Institute)
Cited by 136
Related Papers
Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers
|Angewandte Chemie International Edition|2011|618
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells
|Cancer Cell|2016|416
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
|New England Journal of Medicine|2024|145